معرفی
Xinzhong Li is a Research Professor at Teesside University's SHLS Life Sciences Centre for Biodiscovery. He holds degrees from Xi'an Jiaotong University (BSc, MSc, PhD) and has prior experience at Imperial College London and Plymouth University. His research focuses on bioinformatics, systems biology, and neurodegenerative diseases like Alzheimer’s and brain cancer. He leads major grants, including the €3.9m TClock4AD project targeting circadian clock dysfunction in Alzheimer’s and the Net4Brain Action Network against brain cancer. Key collaborations include work with institutions in Berlin, Israel, and China. His methodologies span machine learning, next-generation sequencing, and biomarker discovery, with applications in diagnostics and drug repurposing. Projects highlight interdisciplinary approaches in healthcare technology and molecular diagnostics.
Dr. Li’s research portfolio includes advanced imaging techniques (e.g., low-dose CT artifact suppression), marine genomics (sea anemone toxins), and business models for healthcare innovation. He has contributed to over 24 peer-reviewed articles and 7 datasets. His grants total millions in funding, emphasizing translational research and international collaboration. Current collaborations involve Prof. Illana Gozea (Tel Aviv University) and Prof. James Scott (Imperial College London). The Teesside lab under his leadership supports interdisciplinary teams addressing critical health challenges through cutting-edge bioinformatics and systems biology approaches.
Labs/Teams: His work is anchored at the SHLS Life Sciences Centre, collaborating with global networks like the AiPBAND and BBDiag consortia. These platforms develop diagnostic tools and therapeutic strategies for brain cancers and Alzheimer’s, leveraging multi-omics data and AI-driven pipelines.
